devSEEK® Sequence Analysis for Neurodevelopmental Disorders
Next Generation Sequencing panel focused on genes implicated in Developmental Delay, Intellectual Disability and Autism Spectrum Disorders
Developmental delay, intellectual disability, and autism spectrum disorders are diverse neurodevelopmental disorders. Multiple lines of evidence support the strong role of genetics in the etiology of these disorders. Courtagen’s Next Generation Sequencing Panel enables the rapid analysis of genes most commonly associated with genetic syndromes as well as nonsyndromic forms of these disorders.Obtaining genetic test results helps determine whether a known etiology is present. A definitive diagnosis facilitates appropriate medical, developmental, educational and community support interventions to optimize child and family well-being. Additional analysis of exon-sized (and larger) deletion and duplication variants in 28 genes is available as an add-on for the devSEEK panel.
Disorders Included in this Next Generation Sequencing Panel
Product Information Sheet
Courtagen's Unmatched Customer SupportTurn Around Time: 4-6 weeks. Results are delivered in weeks, not months.
Saliva Sample: DNA for sequencing is reliably extracted from a single saliva sample. No blood draw or muscle biopsy required. (Whole blood and tissue are accepted, as requested.)
Insurance Assistance: Courtagen works with patients, physicians, and insurance carriers to pre-approve each test. Courtagen will bill the insurance company, and is willing to handle an appeal process as needed.
Courtagen Care Financial Assistance Program: Provides financial assistance to patients based on demonstrated financial need. A qualified applicant may be asked to contribute between $0 and a maximum cost sharing of $200 depending on determination of financial need.
Online Portal: A secure physician online portal is available for ordering genetic tests and accessing patient reports when completed.
Genetic Counselors: Available to address physician’s questions regarding Courtagen test results. Contact us at firstname.lastname@example.org.
Clinical Experience: Courtagen’s Medical Director, Laboratory Director, and variant science team have over 25 years of experience in the treatment and genetic interpretation of neurological and metabolic disorders.
Reports: Utilizing Courtagen’s customized Ziphyr® informatics pipeline and thorough clinical evaluation, each report is provided in a concise format with interpretation and recommendations for consideration.